Foghorn Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Foghorn Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q4 2024.
Foghorn Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$24M, a 5.71% increase year-over-year.
Foghorn Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$103M, a 4.84% increase year-over-year.
Foghorn Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$103M, a 4.84% increase from 2023.
Foghorn Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$108M, a 7.88% increase from 2022.
Foghorn Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$117M, a 16.3% decline from 2021.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2024	-$103M	-$24M	+$1.45M	+5.71%	Oct 1, 2024	Dec 31, 2024	10-K	2025-03-06
Q3 2024	-$104M	-$23.9M	-$6.77M	-39.6%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-04
Q2 2024	-$97.4M	-$26.6M	+$5.42M	+16.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$103M	-$28.2M	+$5.12M	+15.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	-$108M	-$25.5M	+$6.43M	+20.2%	Oct 1, 2023	Dec 31, 2023	10-K	2025-03-06
Q3 2023	-$114M	-$17.1M	+$11.2M	+39.6%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-04
Q2 2023	-$126M	-$32.1M	-$2.86M	-9.81%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$123M	-$33.3M	-$5.51M	-19.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-06
Q4 2022	-$117M	-$31.9M	-$3.8M	-13.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-07
Q3 2022	-$113M	-$28.3M	-$2M	-7.61%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	-$111M	-$29.2M	-$5.93M	-25.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-04
Q1 2022	-$105M	-$27.8M	-$4.67M	-20.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-08
Q4 2021	-$101M	-$28.1M	-$7.3M	-35.1%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-09
Q3 2021	-$93.4M	-$26.3M	-$7.77M	-42%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	-$85.7M	-$23.3M	-$7.72M	-49.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	-$77.9M	-$23.1M	-$9.41M	-68.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-09
Q4 2020	-$68.5M	-$20.8M			Oct 1, 2020	Dec 31, 2020	10-K/A	2022-08-09
Q3 2020		-$18.5M	-$5.39M	-41.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020		-$15.5M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-10
Q1 2020		-$13.7M			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q3 2019		-$13.1M			Jul 1, 2019	Sep 30, 2019	10-Q	2020-12-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.